Recurrent Ovarian Germ Cell Tumor Terminated Phase 1 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01233505Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsTreatment